Dominick Joseph Angiolillo


Ontology type: schema:Person     


Person Info

NAME

Dominick Joseph

SURNAME

Angiolillo

Publications in SciGraph latest 50 shown

  • 2022-09-01 Impact of diabetes mellitus on the pharmacodynamic effects of prasugrel and ticagrelor after switching from clopidogrel in patients with coronary artery disease in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2022-08-29 Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2022-08-24 A Comprehensive Review of the Pleiotropic Effects of Ticagrelor in CARDIOVASCULAR DRUGS AND THERAPY
  • 2022-06-18 Antacid Therapy in Coronary Artery Disease and Heart Failure: Proton Pump Inhibitors vs. H2 Receptor Blockers in CARDIOVASCULAR DRUGS AND THERAPY
  • 2022-06-13 P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention in NATURE REVIEWS CARDIOLOGY
  • 2022-01-20 Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation in CLINICAL PHARMACOKINETICS
  • 2021-08-23 Bleeding avoidance strategies in percutaneous coronary intervention in NATURE REVIEWS CARDIOLOGY
  • 2021-04-16 Cilostazol: a Review of Basic Mechanisms and Clinical Uses in CARDIOVASCULAR DRUGS AND THERAPY
  • 2021-03-11 Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2021-02-13 Use of the VerifyNow point of care assay to assess the pharmacodynamic effects of loading and maintenance dose regimens of prasugrel and ticagrelor in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2020-10-16 Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial in CARDIOVASCULAR DIABETOLOGY
  • 2020-08-14 MRP4 over-expression has a role on both reducing nitric oxide-dependent antiplatelet effect and enhancing ADP induced platelet activation in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2020-08-05 Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural management in NATURE REVIEWS CARDIOLOGY
  • 2020-08-03 Correction: Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection in GENETICS IN MEDICINE
  • 2020-07-17 Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection in GENETICS IN MEDICINE
  • 2020-02-20 Bioavailability of aspirin in fasted and fed states of a novel pharmaceutical lipid aspirin complex formulation in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2020-01-17 Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease in NATURE REVIEWS CARDIOLOGY
  • 2020-01-10 Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial in CLINICAL RESEARCH IN CARDIOLOGY
  • 2019-08-16 Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid–aspirin complex: results of a randomized, crossover, bioequivalence study in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2019-04-19 De-escalation from ticagrelor to clopidogrel in acute coronary syndrome patients: a systematic review and meta-analysis in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2018-07-04 Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention in NATURE REVIEWS CARDIOLOGY
  • 2018-04-11 Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2017-08-24 Effects of statin therapy on platelet reactivity after percutaneous coronary revascularization in patients with acute coronary syndrome in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2017-06-12 Platelet-related biomarkers and their response to inhibition with aspirin and p2y12-receptor antagonists in patients with acute coronary syndrome in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2017-02-23 Antithrombotic therapy for patients with STEMI undergoing primary PCI in NATURE REVIEWS CARDIOLOGY
  • 2016-11-17 The Rationale for and Clinical Pharmacology of Prasugrel 5 mg in AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS
  • 2016-11-08 Clinical Pharmacology and Cardiovascular Safety of Naproxen in AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS
  • 2016-08-19 Intracoronary Bivalirudin Bolus in ST-Elevation Myocardial Infarction Patients Treated with Primary Angioplasty: Theoretical Bases, Clinical Experience, and Future Applications in AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS
  • 2016-08-04 Antithrombotic therapy for secondary prevention of atherothrombotic events in cerebrovascular disease in NATURE REVIEWS CARDIOLOGY
  • 2015-08-18 Switching P2Y12-receptor inhibitors in patients with coronary artery disease in NATURE REVIEWS CARDIOLOGY
  • 2015-05-30 Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trials in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2015-03-12 Comparison of the pharmacodynamic effects of ranolazine versus amlodipine on platelet reactivity in stable patients with coronary artery disease treated with dual antiplatelet therapy in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2015-01-30 Impact of impaired glucose tolerance on clopidogrel response in patients with coronary artery disease in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2014-10-11 A randomised trial of the pharmacodynamic and pharmacokinetic effects of ticagrelor compared with clopidogrel in Hispanic patients with stable coronary artery disease in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2014-10-07 Novel antiplatelet agents in acute coronary syndrome in NATURE REVIEWS CARDIOLOGY
  • 2014-08-28 Percutaneous coronary intervention and atrial fibrillation: the triple therapy dilemma in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2014-08-17 Role of thromboelastography and rapid thromboelastography to assess the pharmacodynamic effects of vitamin K antagonists in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2014-03-22 Platelet Function Testing in Contemporary Clinical and Interventional Practice in CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE
  • 2014-01-07 Cigarette Smoking and Antiplatelet Effects of Aspirin Monotherapy Versus Clopidogrel Monotherapy in Patients with Atherosclerotic Disease: Results of a Prospective Pharmacodynamic Study in JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH
  • 2013-12-27 Randomized Comparison of Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome and Planned Invasive Strategy—Design and Rationale of the Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5 Trial in JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH
  • 2013-12-25 Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2013-12-21 Impact of Mild Hypothermia on Platelet Responsiveness to Aspirin and Clopidogrel: an In Vitro Pharmacodynamic Investigation in JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH
  • 2013-12-20 Impact of Cigarette Smoking on P2Y12 Receptor Binding Activity Before and After Clopidogrel Therapy in Patients with Coronary Artery Disease in JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH
  • 2013-12-20 Antithrombotic Issues in Women in MANAGEMENT OF CARDIOVASCULAR DISEASE IN WOMEN
  • 2013-10-08 Erratum to: Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigation in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2013-09-17 Higher body weight patients on clopidogrel maintenance therapy have lower active metabolite concentrations, lower levels of platelet inhibition, and higher rates of poor responders than low body weight patients in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2013-08-14 Anticoagulation Therapy. Heparins, Factor II and Factor Xa Inhibitors in PHARMACOLOGICAL TREATMENT OF ACUTE CORONARY SYNDROMES
  • 2013-08-14 Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigation in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2013-07-14 Pharmacodynamic effects of adjunctive high dose atorvastatin on double dose clopidogrel in patients with high on-treatment platelet reactivity depending on diabetes mellitus status in JOURNAL OF THROMBOSIS AND THROMBOLYSIS
  • 2013-04-24 Antiplatelet and Anticoagulant Therapy for Atherothrombotic Disease: The Role of Current and Emerging Agents in AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.15276.37", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411068.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.38142.3c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.189509.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.419794.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416167.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.59734.3c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415050.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.15496.3f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413116.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.39936.36", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.62560.37", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414420.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418152.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.26009.3d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413574.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.8142.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5611.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418424.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.8158.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415235.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414924.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414056.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.489893.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415502.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414270.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5841.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.1006.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418668.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.17063.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5522.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.239395.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411544.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.460094.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413615.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.482476.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411129.e", 
            "type": "Organization"
          }
        ], 
        "familyName": "Angiolillo", 
        "givenName": "Dominick Joseph", 
        "id": "sg:person.01144446702.77", 
        "identifier": [
          {
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0001-8451-2131"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144446702.77", 
          "https://orcid.org/0000-0001-8451-2131"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-11-24T21:37", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/person/person_815.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01144446702.77'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01144446702.77'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01144446702.77'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01144446702.77'


     

    This table displays all metadata directly associated to this object as RDF triples.

    93 TRIPLES      11 PREDICATES      49 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.01144446702.77 schema:affiliation Ne3780814b5a6436485673328b7932a55
    2 grid-institutes:grid.1006.7
    3 grid-institutes:grid.15496.3f
    4 grid-institutes:grid.17063.33
    5 grid-institutes:grid.189509.c
    6 grid-institutes:grid.239395.7
    7 grid-institutes:grid.26009.3d
    8 grid-institutes:grid.38142.3c
    9 grid-institutes:grid.39936.36
    10 grid-institutes:grid.411068.a
    11 grid-institutes:grid.411129.e
    12 grid-institutes:grid.411544.1
    13 grid-institutes:grid.413116.0
    14 grid-institutes:grid.413574.0
    15 grid-institutes:grid.413615.4
    16 grid-institutes:grid.414056.2
    17 grid-institutes:grid.414270.4
    18 grid-institutes:grid.414420.7
    19 grid-institutes:grid.414924.e
    20 grid-institutes:grid.415050.5
    21 grid-institutes:grid.415235.4
    22 grid-institutes:grid.415502.7
    23 grid-institutes:grid.416167.3
    24 grid-institutes:grid.418152.b
    25 grid-institutes:grid.418424.f
    26 grid-institutes:grid.418668.5
    27 grid-institutes:grid.419794.6
    28 grid-institutes:grid.460094.f
    29 grid-institutes:grid.482476.b
    30 grid-institutes:grid.489893.7
    31 grid-institutes:grid.5522.0
    32 grid-institutes:grid.5611.3
    33 grid-institutes:grid.5841.8
    34 grid-institutes:grid.59734.3c
    35 grid-institutes:grid.62560.37
    36 grid-institutes:grid.8142.f
    37 grid-institutes:grid.8158.4
    38 schema:familyName Angiolillo
    39 schema:givenName Dominick Joseph
    40 schema:identifier Nfd93f802ebb449b1abc1b7f970af3d31
    41 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144446702.77
    42 https://orcid.org/0000-0001-8451-2131
    43 schema:sdDatePublished 2022-11-24T21:37
    44 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    45 schema:sdPublisher Na971f3a51f3e4bae8557462aa9169f93
    46 sgo:license sg:explorer/license/
    47 sgo:sdDataset persons
    48 rdf:type schema:Person
    49 Na971f3a51f3e4bae8557462aa9169f93 schema:name Springer Nature - SN SciGraph project
    50 rdf:type schema:Organization
    51 Ne3780814b5a6436485673328b7932a55 schema:affiliation grid-institutes:grid.15276.37
    52 sgo:isCurrent true
    53 rdf:type schema:OrganizationRole
    54 Nfd93f802ebb449b1abc1b7f970af3d31 schema:name orcid_id
    55 schema:value 0000-0001-8451-2131
    56 rdf:type schema:PropertyValue
    57 grid-institutes:grid.1006.7 schema:Organization
    58 grid-institutes:grid.15276.37 schema:Organization
    59 grid-institutes:grid.15496.3f schema:Organization
    60 grid-institutes:grid.17063.33 schema:Organization
    61 grid-institutes:grid.189509.c schema:Organization
    62 grid-institutes:grid.239395.7 schema:Organization
    63 grid-institutes:grid.26009.3d schema:Organization
    64 grid-institutes:grid.38142.3c schema:Organization
    65 grid-institutes:grid.39936.36 schema:Organization
    66 grid-institutes:grid.411068.a schema:Organization
    67 grid-institutes:grid.411129.e schema:Organization
    68 grid-institutes:grid.411544.1 schema:Organization
    69 grid-institutes:grid.413116.0 schema:Organization
    70 grid-institutes:grid.413574.0 schema:Organization
    71 grid-institutes:grid.413615.4 schema:Organization
    72 grid-institutes:grid.414056.2 schema:Organization
    73 grid-institutes:grid.414270.4 schema:Organization
    74 grid-institutes:grid.414420.7 schema:Organization
    75 grid-institutes:grid.414924.e schema:Organization
    76 grid-institutes:grid.415050.5 schema:Organization
    77 grid-institutes:grid.415235.4 schema:Organization
    78 grid-institutes:grid.415502.7 schema:Organization
    79 grid-institutes:grid.416167.3 schema:Organization
    80 grid-institutes:grid.418152.b schema:Organization
    81 grid-institutes:grid.418424.f schema:Organization
    82 grid-institutes:grid.418668.5 schema:Organization
    83 grid-institutes:grid.419794.6 schema:Organization
    84 grid-institutes:grid.460094.f schema:Organization
    85 grid-institutes:grid.482476.b schema:Organization
    86 grid-institutes:grid.489893.7 schema:Organization
    87 grid-institutes:grid.5522.0 schema:Organization
    88 grid-institutes:grid.5611.3 schema:Organization
    89 grid-institutes:grid.5841.8 schema:Organization
    90 grid-institutes:grid.59734.3c schema:Organization
    91 grid-institutes:grid.62560.37 schema:Organization
    92 grid-institutes:grid.8142.f schema:Organization
    93 grid-institutes:grid.8158.4 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...